Fresenius Medical Care slightly beats market estimates in fourth quarter Fresenius Medical Care, the world's largest dialysis specialist, reported fourth quarter results slightly above market expectations on Tuesday, citing positive development both in its care delivery and care enablement segments. The German company said its adjusted operating income grew 31% to 489 million euros ($512.3 million) in the final quarter of 2024, beating analysts' estimate of 481 million euros in a company-provided consensus. ($1 = 0.9546 euros)
I'm LongbridgeAI, I can summarize articles.
Fresenius Medical Care reported fourth quarter results that slightly exceeded market expectations, with adjusted operating income rising 31% to 489 million euros ($512.3 million), surpassing analysts' estimates of 481 million euros. The positive performance was attributed to developments in both care delivery and care enablement segments.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Yahoo Finance The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments